Manufacturing News and Research

RSS
CytRx commences INNO-206 Phase 1b trial in advanced solid tumors

CytRx commences INNO-206 Phase 1b trial in advanced solid tumors

Sparton announces contract manufacturing award from Talyst

Sparton announces contract manufacturing award from Talyst

Highmark forces patients with PIDD to switch over to specific IgG therapy

Highmark forces patients with PIDD to switch over to specific IgG therapy

FAO head highlights food security concerns, need for more agriculture investment

FAO head highlights food security concerns, need for more agriculture investment

MorphoSys inks manufacturing agreement with Boehringer Ingelheim

MorphoSys inks manufacturing agreement with Boehringer Ingelheim

Genesis Biopharma to establish Adoptive Cell Immunotherapy based therapeutic development program

Genesis Biopharma to establish Adoptive Cell Immunotherapy based therapeutic development program

RegeneRx RGN-352 Phase 2 trial in acute myocardial infarction placed on clinical hold

RegeneRx RGN-352 Phase 2 trial in acute myocardial infarction placed on clinical hold

Millennium, SGEN expand ADC collaboration

Millennium, SGEN expand ADC collaboration

Medicago receives $3.8M as second milestone payment from U.S. DARPA for cGMP vaccine facility

Medicago receives $3.8M as second milestone payment from U.S. DARPA for cGMP vaccine facility

ShangPharma fourth quarter net revenues increase 29.4% to $25.6 million

ShangPharma fourth quarter net revenues increase 29.4% to $25.6 million

Indium oxine in development at Positron's Crown Point facility

Indium oxine in development at Positron's Crown Point facility

Daylight Solutions ships its 200th commercial laser system for scientific applications

Daylight Solutions ships its 200th commercial laser system for scientific applications

ChromaDex pTeroPure Pterostilbene receives 2010 Most Promising Ingredient of the Year award

ChromaDex pTeroPure Pterostilbene receives 2010 Most Promising Ingredient of the Year award

Halozyme Therapeutics 2010 net loss decreases to $53.2 million

Halozyme Therapeutics 2010 net loss decreases to $53.2 million

Sonitus Medical's SoundBite Hearing System receives CE Mark certification

Sonitus Medical's SoundBite Hearing System receives CE Mark certification

FDA announces consent decree of permanent injunction against McNeil-PPC

FDA announces consent decree of permanent injunction against McNeil-PPC

FDA holds Senesco's SNS01-T clinical study due to delay of supplier's DMF updation

FDA holds Senesco's SNS01-T clinical study due to delay of supplier's DMF updation

Harvard, Oxford Nanopore enter exclusive agreement for graphene DNA sequencing

Harvard, Oxford Nanopore enter exclusive agreement for graphene DNA sequencing

FDA approves Matrix NDA for Zidovudine Tablets

FDA approves Matrix NDA for Zidovudine Tablets

FDA approves Covidien's LEU-based Mo-99 medical isotope

FDA approves Covidien's LEU-based Mo-99 medical isotope

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.